Open AccessVAGINAL APPLICATION OF A CHEMOTHERAPEUTIC AGENT BEFORE LEGAL ABORTION
Author(s) -
Meirik Olav,
Nilsson Staffan,
Nygren KarlGÖSta
Publication year - 1981
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016348109158123
Subject(s) - medicine , abortion , incidence (geometry) , vacuum aspiration , obstetrics , first trimester , incomplete abortion , pregnancy , gynecology , family planning , gestation , misoprostol , research methodology , population , genetics , physics , environmental health , optics , biology
. In an attempt to reduce the incidence of infectious complications after first trimester legal abortion 199 healthy, early pregnant women were treated with chloro‐quinaldol (Sterosan R vaginal jelly) during six days before their vacuum aspiration. A group of 291 women served as control. In the treatment group 18 women (9%) had a postoperative gynecological infection while this condition was found in 37 women (12.8%) in the control group. This difference is not statistically significant. The authors conclude that preoperative prophylactic treatment with Sterosan vaginal jelly does not seem to reduce postoperative infectious complications after first trimester legal abortions.